Product image of Lenzetto (Estradiol) supplied by GNH India

Lenzetto

Active Ingredient:
Estradiol
Origin:
EU

Lenzetto (Estradiol)

Estradiol, the active ingredient in Lenzetto, is an estrogen presented as a transdermal patch for transdermal administration. It is indicated for relief of menopausal vasomotor symptoms, correction of estrogen deficiency, and as part of hormone‑replacement therapy to reduce the risk of osteoporosis in postmenopausal women. The product complies with EU regulatory standards and is available by prescription.

GNH India supplies Lenzetto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across all markets.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lenzetto provides systemic estrogen through a transdermal delivery system, addressing conditions related to estrogen deficiency.
  • Menopausal vasomotor symptoms: alleviates hot flashes and night sweats in postmenopausal women.
  • Estrogen deficiency: restores hormonal balance in women with hypoestrogenism.
  • Prevention of osteoporosis: contributes to bone density maintenance to lower fracture risk.
  • Hormone replacement therapy: supports overall estrogen levels as part of comprehensive HRT regimens.

How It Works

  • Estradiol in Lenzetto binds to intracellular estrogen receptors (ERα and ERβ), forming a hormone‑receptor complex that translocates to the nucleus and modulates transcription of estrogen‑responsive genes. This activation influences multiple physiological pathways, including regulation of the hypothalamic‑pituitary‑gonadal axis, bone remodeling, and vascular function, thereby correcting estrogen deficiency and mitigating related symptoms.

Side Effects

Common Side Effects

  • Skin irritation at the patch site: redness, itching or rash where the patch is applied.
  • Headache: mild to moderate intensity, often transient.
  • Breast tenderness: discomfort or swelling of breast tissue.
  • Nausea: occasional upset stomach or feeling of queasiness.
  • Mood changes: irritability or mild mood swings.

Serious or Rare Side Effects

  • Thromboembolic events: deep vein thrombosis or pulmonary embolism.
  • Stroke or transient ischemic attack: neurological symptoms indicating reduced cerebral blood flow.
  • Myocardial infarction: chest pain or other signs of heart attack.
  • Endometrial hyperplasia or carcinoma: abnormal uterine bleeding or pelvic pain.
  • Gallbladder disease: biliary colic or cholecystitis.
  • Severe hepatic dysfunction: jaundice, elevated liver enzymes.

Precautions & Warnings

  • Before initiating therapy, evaluate individual risk factors and contraindications.
  • Cardiovascular assessment: screen for history of thromboembolic disease or stroke.
  • Breast cancer screening: perform regular mammography as recommended.
  • Liver function monitoring: assess hepatic enzymes in patients with known liver disease.
  • Pregnancy avoidance: ensure effective contraception, as estrogen can affect fetal development.
  • Contraindication in active thromboembolic disease: do not use in patients with current clotting disorders.
  • Store at room temperature: keep in original pouch, protect from light and moisture.

Avoid Interactions

Estradiol may interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce estradiol plasma levels.
  • CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase estradiol exposure and risk of adverse events.
  • Anticoagulants (e.g., warfarin): estrogen can enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely)

  • Thyroid hormone replacement: estradiol may alter thyroid‑binding globulin, affecting hormone levels.
  • Antidiabetic agents: estrogen can influence glucose metabolism, requiring dose adjustments.
  • Lithium: monitor serum lithium concentrations, as estrogen may affect renal clearance.

Frequently Asked Questions

Lenzetto is a prescription transdermal patch that delivers estradiol, an estrogen, to treat menopausal vasomotor symptoms such as hot flashes, to correct estrogen deficiency, and to help prevent osteoporosis in postmenopausal women as part of hormone‑replacement therapy.

Estradiol in Lenzetto binds to estrogen receptors inside cells, forming a complex that enters the nucleus and regulates the transcription of estrogen‑responsive genes. This modulation restores hormonal balance, influences bone remodeling, and alleviates vasomotor symptoms associated with low estrogen levels.

The appropriate dose of Lenzetto is determined by the prescribing healthcare professional based on the individual’s clinical condition, severity of symptoms, and treatment goals. Patients should follow the prescriber’s instructions and not alter the dosing regimen without medical advice.

Lenzetto is generally contraindicated in pregnancy because exogenous estrogen can affect fetal development. Women who are pregnant, planning to become pregnant, or are breastfeeding should discuss alternative therapies with their healthcare provider.

To order Lenzetto, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lenzetto delivers estradiol transdermally, bypassing first‑pass hepatic metabolism, which can result in more stable plasma concentrations and potentially lower risk of liver‑related side effects compared with oral tablets. However, both forms aim to restore estrogen levels, and the choice depends on patient preference, tolerability and clinical considerations.

Lenzetto should be stored at room temperature, below 25 °C, in its original packaging. Keep the patches away from direct sunlight, moisture and heat sources. Do not expose the product to temperatures above the recommended range, and discard any patch that appears damaged.

The patch is applied to clean, dry, and hair‑free skin on the abdomen, buttock, or upper arm. Press firmly for several seconds to ensure adhesion, and rotate the application site with each new patch to minimize skin irritation. Follow the prescriber’s schedule for patch changes.

Serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, stroke, myocardial infarction, endometrial hyperplasia or carcinoma, and severe hepatic dysfunction. Patients should be monitored for signs of these conditions and seek immediate medical attention if symptoms arise.

Lenzetto is contraindicated in women with known or suspected estrogen‑dependent malignancies, active or past thromboembolic disease, uncontrolled hypertension, liver disease, or those who are pregnant. It should also be used with caution in patients with a history of cardiovascular disease or gallbladder disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Estradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT